Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Epsin-2 is an endocytic adaptor protein, characterized by an epsin N-terminal homology (ENTH) domain that binds phosphoinositides and inserts into the plasma membrane, inducing curvature necessary for the formation and maturation of clathrin-coated pits and vesicles during endocytosis. The C-terminal domain is intrinsically disordered and interacts with clathrin and adaptor proteins such as AP-2, stabilizing endocytic complexes under varying membrane tension. Epsin-2 is expressed in the brain and may be involved in neuronal vesicle trafficking, as well as in broader cellular events related to membrane dynamics, cargo recruitment, and protein-protein interactions in regulated endocytosis. Studies in yeast and mammalian cells indicate epsins coordinate endocytosis with cell polarity and cell division by interacting with regulators of small GTPases (e.g., Cdc42), and may have roles in disease states such as cancer and neurodegeneration. Alternative splicing generates isoforms with potentially different activities.
No drugs directly target this protein; theoretically, compounds that interfere with ENTH domain interactions, clathrin binding, or membrane curvature could modulate its function.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Epsin-2 (EPN2).